The latent structure and predictors of non-medical prescription drug use and prescription drug use disorders: A National Study

Drug and Alcohol Dependence

Volumn 133, Issue 2, 2013, Pages 473-479

  Blanco, Carlos ^a   Rafful, Claudia ^a   Wall, Melanie M ^a   Jin, Chelsea J ^a   Kerridge, Bradley ^b   Schwartz, Robert P ^c  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c FRIENDS RESEARCH INSTITUTE   (United States)

Author keywords

Latent structure; NESARC; Non medical prescription drug use; Prescription drug use disorders

Indexed keywords

APPETITE STIMULANT; NON PRESCRIPTION DRUG; OPIATE; OPIATE RECEPTOR; PRESCRIPTION DRUG; SEDATIVE AGENT; TRANQUILIZER;

ADULT; AGE DISTRIBUTION; ALCOHOL ABUSE; ALCOHOLISM; ANTISOCIAL PERSONALITY DISORDER; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DEPENDENCE; FEMALE; HISTRIONIC PERSONALITY DISORDER; HUMAN; LATENT STRUCTURE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; OBSESSIVE COMPULSIVE DISORDER; PARANOIA; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; SCHIZOIDISM; SEX DIFFERENCE; TEST RETEST RELIABILITY;

LATENT STRUCTURE; NESARC; NON-MEDICAL PRESCRIPTION DRUG USE; PRESCRIPTION DRUG USE DISORDERS;

ADOLESCENT; ALCOHOLISM; ANALGESICS, OPIOID; ANTI-ANXIETY AGENTS; ANXIETY; CENTRAL NERVOUS SYSTEM STIMULANTS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; METHAMPHETAMINE; PAIN; PAIN MEASUREMENT; PRESCRIPTION DRUG MISUSE; SUBSTANCE-RELATED DISORDERS; UNITED STATES; YOUNG ADULT;

EID: 84887022326     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2013.07.011     Document Type: Article

References (50)

1. Agrawal A., Lynskey M.T., Madden P.A.F., Bucholz K.K., Heath A.C. A latent class analysis of illicit drug abuse/dependence: results from the National Epidemiological Survey on Alcohol and Related Conditions. Addiction 2006, 102:94-104.
2. Blanco C., Alderson D., Ogburn E., Grant B.F., Nunes E.V., Hatzenbuehler M.L., Hasin D.S. Changes in the prevalence of non-medical prescription drug use and drug use disorders in the United States: 1991-1992 and 2001-2002. Drug Alcohol Depend. 2007, 90:252-260.
3. Blanco C., Iza M., Schwartz R.P., Rafful C., Wang S., Olfson M. Probability and predictors of treatment-seeking for prescription opioid use disorders: a national study. Drug Alcohol Depend. 2013, 131:143-148.
4. Blanco C., Krueger R.F., Hasin D.S., Liu S.M., Wang S., Kerridge B.T., Saha T., Olfson M. Mapping common psychiatric disorders: structure and predictive validity in the National Epidemiologic Survey on Alcohol and Related Conditions. JAMA Psychiatry 2013, 70:199-208.
5. Blanco C., Secades-Villa R., Garcia-Rodriguez O., Labrador-Mendez M., Wang S., Schwartz R.P. Probability and predictors of remission from life-time prescription drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J. Psychiatr. Res. 2013, 47:42-49.
6. Bohnert A.S.B., Fudalej S., Ilgen M.A. Increasing poisoning mortality rates in the United States, 1999-2006. Public Health Rep. 2010, 125:542-547.
7. Bohnert A.S.B., Valenstein M., Bair M.J., Ganoczy D., McCarthy J.F., Ilgen M.A., Blow F.C. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 2011, 305:1315-1321.
8. Compton W.M., Thomas Y.F., Stinson F.S., Grant B.F. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch. Gen. Psychiatry 2007, 64:566-576.
9. Compton W.M., Volkow N.D. Abuse of prescription drugs and the risk of addiction. Drug Alcohol Depend. 2006, 83:S4-S7.
10. Fenton M.C., Keyes K.M., Martins S.S., Hasin D.S. The role of a prescription in anxiety medication use, abuse, and dependence. Am. J. Psychiatry 2010, 167:1247-1253.
11. Fischer B., Lusted A., Roerecke M., Taylor B. The prevalence of mental health and pain symptoms in general population samples reporting nonmedical use of prescription opioids: a systematic review and meta-analysis. J. Pain 2012, 13:1029-1044.
12. Grant B.F., Dawson D.A., Stinson F.S., Chou P.S., Kay W., Pickering R. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend. 2003, 71:7-16.
13. Grant B.F., Goldstein R.B., Chou S.P., Huang B., Stinson F.S., Dawson D.A., Saha T.D., Smith S.M., Pulay A.J., Pickering R.P. Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Mol. Psychiatry 2009, 14:1051-1066.
14. Grant B.F., Harford T.C., Dawson D.A., Chou P.S., Pickering R.P. The Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS): reliability of alcohol and drug modules in a general population sample. Drug Alcohol Depend. 1995, 39:37-44.
15. Grant B.F., Stinson F.S., Dawson D.A., Chou S.P., Dufour M.C., Compton W., Pickering R.P., Kaplan K. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch. Gen. Psychiatry 2004, 61:807-816.
16. Grant B.F., Stinson F.S., Dawson D.A., Chou S.P., Ruan W., Pickering R.P. Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch. Gen. Psychiatry 2004, 61:361-368.
17. Hall A.J., Logan J.E., Toblin R.L., Kaplan J.A., Kraner J.C., Bixler D., Crosby A.E., Paulozzi L.J. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 2008, 300:2613-2620.
18. Hasin D., Fenton M.C., Skodol A., Krueger R., Keyes K., Geier T., Greenstein E., Blanco C., Grant B. Personality disorders and the 3-year course of alcohol, drug, and nicotine use disorders. Arch. Gen. Psychiatry 2011, 68:1158-1167.
19. Hasin D.S., Stinson F.S., Ogburn E., Grant B.F. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch. Gen. Psychiatry 2007, 64:830-842.
20. Hernandez S.H., Nelson L.S. Prescription drug abuse: insight into the epidemic. Clin. Pharmacol. Ther. 2010, 88:307-317.
21. Hu L., Bentler P.M., Kano Y. Can test statistics in covariance structure analysis be trusted?. Psychol. Bull. 1992, 112:351-362.
22. Joreskog K., Moustaki I. Factor analysis of ordinal variables: a comparison of three approaches. Multivariate Behav. Res. 2001, 36:347-387.
23. Kaloyanides K.B., McCabe S.E., Cranford J.A., Teter C.J. Prevalence of illicit use and abuse of prescription stimulants, alcohol, and other drugs among college students: relationship with age at initiation of prescription stimulants. Pharmacotherapy 2007, 27:666-674.
24. Keyes K.M., Schulenberg J.E., O'Malley P.M., Johnston L.D., Bachman J.G., Li G., Hasin D. Birth cohort effects on adolescent alcohol use: the influence of social norms from 1976 to 2007. Arch. Gen. Psychiatry 2012, 69:1304-1313.
25. Kim E.S., Yoon M., Lee T. Testing measurement invariance using MIMIC: likelihood ratio test with a critical value adjustment. Educ. Psychol. Meas. 2011, 72:469-492.
26. Krueger R.F. The structure of common mental disorders. Arch. Gen. Psychiatry 1999, 56:921-926.
27. Lopez-Quintero C., Cobos J.P., Hasin D.S., Okuda M., Wang S., Grant B.F., Blanco C. Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend. 2011, 115:120-130.
28. Manchikanti L. National drug control policy and prescription drug abuse: facts and fallacies. Pain Physician 2007, 10:399-424.
29. Markon K.E., Krueger R.F. Categorical and continuous models of liability to externalizing disorders: a direct comparison in NESARC. Arch. Gen. Psychiatry 2005, 62:1352-1359.
30. Martins S., Fenton M., Keyes K., Blanco C., Zhu H., Storr C. Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions. Psychol. Med. 2012, 42:1261-1272.
31. Martins S.S., Keyes K.M., Storr C.L., Zhu H., Chilcoat H.D. Pathways between nonmedical opioid use/dependence and psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend. 2009, 103:16-24.
32. McCabe S.E., Cranford J.A., Boyd C.J. The relationship between past-year drinking behaviors and nonmedical use of prescription drugs: prevalence of co-occurrence in a national sample. Drug Alcohol Depend. 2006, 84:281-288.
33. McCabe S.E., Cranford J.A., West B.T. Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: results from two national surveys. Addict. Behav. 2008, 33:1297-1305.
34. McCabe S.E., Teter C.J., Boyd C.J., Knight J.R., Wechsler H. Nonmedical use of prescription opioids among US college students: prevalence and correlates from a national survey. Addict. Behav. 2005, 30:789-805.
35. Muthen L.K., Muthen B.O. Mplus Version 4 User's Guide 2006, Muthen & Muthen, Los Angeles.
36. Olfson M., Blanco C., Wang S., Greenhill L.L. Trends in office-based treatment of adults with stimulants in the United States. J. Clin. Psychiatry 2013, 74:43-50.
37. Olfson M., Crystal S., Iza M., Wang S., Blanco C. National trends in office-based prescription of schedulle II opioids. J. Clin. Psychiatry 2013, (in press).
38. Paulozzi L.J., Budnitz D.S., Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol. Drug Saf. 2006, 15:618-627.
39. Poulin C. From attention-deficit/hyperactivity disorder to medical stimulant use to the diversion of prescribed stimulants to non-medical stimulant use: connecting the dots. Addiction 2007, 102:740-751.
40. Resnik D.B., Rehm M. The undertreatment of pain: scientific, clinical, cultural, and philosophical factors. Med. Health Care Philos. 2001, 4:277-288.
41. Robinson J., Sareen J., Cox B.J., Bolton J.M. Role of self-medication in the development of comorbid anxiety and substance use disorders: a longitudinal investigation. Arch. Gen. Psychiatry 2011, 68:800-807.
42. Ruan W., Goldstein R.B., Chou S.P., Smith S.M., Saha T.D., Pickering R.P., Dawson D.A., Huang B., Stinson F.S., Grant B.F. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of new psychiatric diagnostic modules and risk factors in a general population sample. Drug Alcohol Depend. 2008, 92:27-36.
43. SAMHSA Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings 2011, Substance Abuse and Mental Health Services Administration, Rockville, MD.
44. Schepis T.S., Hakes J.K. Non-medical prescription use increases the risk for the onset and recurrence of psychopathology: results from the National Epidemiological Survey on Alcohol and Related Conditions. Addiction 2011, 106:2146-2155.
45. Simoni-Wastila L., Strickler G. Risk factors associated with problem use of prescription drugs. Am. J. Public Health 2004, 94:266-268.
46. Stark S., Chernyshenko O.S., Drasgow F. Detecting differential item functioning with confirmatory factor analysis and item response theory: toward a unified strategy. J. Appl. Psychol. 2006, 91:1292-1306.
47. Swanson J.M., Volkow N.D. Increasing use of stimulants warns of potential abuse. Nature 2008, 453. 586-586.
48. Wang J., Christo P.J. The influence of prescription monitoring programs on chronic pain management. Pain Physician 2009, 12:507-515.
49. Ware J., Kosinski M., Turner-Bowker D.M., Gandek B. SF-12v2: How to Score Version 2 of the SF-12 Health Survey 2002, Quality Metric Incorporated Health Assessment Lab Boston, Massachusetts Lincoln, Rhode Island.
50. Wirth R.J., Edwards M.C. Item factor analysis: current approaches and future directions. Psychol. Methods 2007, 12:58-79.